Impact of an Antimicrobial Stewardship Policy to Restrict Palivizumab Use

J Pediatric Infect Dis Soc. 2019 May 11;8(2):189-190. doi: 10.1093/jpids/pix091.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Antimicrobial Stewardship*
  • Drug Therapy, Computer-Assisted
  • Drug Utilization Review
  • Hospitalization
  • Humans
  • Inappropriate Prescribing / prevention & control
  • Infant
  • Organizational Policy*
  • Palivizumab / therapeutic use*
  • Practice Guidelines as Topic
  • Respiratory Syncytial Virus Infections / drug therapy*
  • Retrospective Studies

Substances

  • Anti-Bacterial Agents
  • Palivizumab